Gisela Paulsen
Direttore operativo presso Harbinger Health
Patrimonio netto: 50 211 $ in data 31/05/2024
Profilo
Gisela Paulsen is currently the Director at Delphi Diagnostics, Inc. and the Chief Operating Officer at Harbinger Health, Inc. He previously worked as the General Manager-Precision Oncology at EXACT Sciences Corp.
from 2020 to 2021 and as the President & Chief Operating Officer at OncoCyte Corp.
in 2022.
Mr. Paulsen received his undergraduate and graduate degrees from the University of Uppsala.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ONCOCYTE CORPORATION
0.14% | 16/12/2022 | 18 325 ( 0.14% ) | 50 211 $ | 31/05/2024 |
Posizioni attive di Gisela Paulsen
| Società | Posizione | Inizio |
|---|---|---|
Delphi Diagnostics, Inc.
 Delphi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delphi Diagnostics, Inc. provides healthcare services. The company was founded in 2016 and is headquartered in Austin, TX. | Direttore/Membro del Consiglio | - |
Harbinger Health
 Harbinger Health Information Technology ServicesTechnology Services Harbinger Health, Inc. is a company based in Cambridge, MA. Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test. Harbinger envisions a future where cancer could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems, and societies. The company fundamentally transforms cancer care for everyone. The company was founded in 2020 by Alexander Meissner, Sidney Farber, Zachary Smith, Franziska Michor. The CEO is Stephen Hahn. | Direttore operativo | 06/09/2023 |
Precedenti posizioni note di Gisela Paulsen
| Società | Posizione | Fine |
|---|---|---|
| ONCOCYTE CORPORATION | Presidente | 16/12/2022 |
| EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 20/04/2021 |
Formazione di Gisela Paulsen
| University of Uppsala | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| EXACT SCIENCES CORPORATION | Health Technology |
| ONCOCYTE CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Delphi Diagnostics, Inc.
Delphi Diagnostics, Inc. Medical/Nursing ServicesHealth Services Delphi Diagnostics, Inc. provides healthcare services. The company was founded in 2016 and is headquartered in Austin, TX. | Health Services |
Harbinger Health
Harbinger Health Information Technology ServicesTechnology Services Harbinger Health, Inc. is a company based in Cambridge, MA. Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. The company combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test. Harbinger envisions a future where cancer could be kept from forming, making a cancer diagnosis a routine health problem to be addressed rather than a life-altering event to be feared with profound implications for people, healthcare systems, and societies. The company fundamentally transforms cancer care for everyone. The company was founded in 2020 by Alexander Meissner, Sidney Farber, Zachary Smith, Franziska Michor. The CEO is Stephen Hahn. | Technology Services |
- Borsa valori
- Insiders
- Gisela Paulsen
